Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
| Autor: | Bruce, Ian N, Nami, Alireza, Schwetje, Erik, Pierson, M Edward, Rouse, Tomas, Chia, Yen Lin, Kuruvilla, Denison, Abreu, Gabriel, Tummala, Raj, Lindholm, Catharina * |
|---|---|
| Zdroj: | In The Lancet Rheumatology February 2021 3(2):e101-e110 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|